Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate

Our goal was to compare subjects treated with glatiramer acetate (GA) and interferon-beta (IFN- β) in terms of long-term clinical outcomes.

Source: Journal of the Neurological Sciences - September 17, 2018 Category: Neurology Authors: Brian C. Healy, Bonnie I. Glanz, Jonathan D. Zurawski, Maria Mazzola, Tanuja Chitnis, Howard L. Weiner Source Type: research